Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Decriminalizing Mental Health with special guest, Caroline Fisher-O’Neill, Esq. During this episode, Caroline informs us on the meaning of “criminalization of mental health” so that we can better understand this disparity. She provides us with some examples of disproportionate criminalization and highlights what is currently being done to swing the pendulum in the opposite direction to decriminalize mental health. Excitedly, Caroline lets us know where we can find more resources on this topic!

Featuring:

Caroline Fisher-O’Neill, Esq.; Director, State Government Affairs, OAPI

Caroline Fisher-O’Neill is the East Director for State Government Affairs at Otsuka. Prior to joining this team, nearly 10 years ago, she worked in the Massachusetts State Legislature on health policy. Serving as the General and Health Policy Counsel to the Senate Chair of the Healthcare Finance Committee, and later as Health Policy Counsel to the Speaker of the House, she gained a significant amount of exposure to the challenges inherent in the healthcare policy landscape. In her current role, she works with the GA team to drive open access to treatments and services for Otsuka’s patient populations and leads initiatives to support Otsuka’s commitment to helping individuals with serious mental illness. She resides in Brooklyn, NY.

Amica Simmons-Yon, PharmD, PhD

Clinical & Scientific Liaison, Otsuka Pharmaceutical Development and Commercialization, Inc.

Alyssa Peckham, PharmD, BCPP

Clinical & Scientific Liaison, Otsuka Pharmaceutical Development and Commercialization, Inc.

Links:

PsychU Interview | Decriminalizing Mental Illness: https://bit.ly/3Nm04WP

PsychU Article | Baton Rouge Area Foundation Plans to Create Community Mental Health Diversion Center: https://bit.ly/3PtZGHW

PsychU Article | Oregon Law To Decriminalize Drug Use Goes Into Effect, Offering Addiction Treatment Instead Of Incarceration: https://bit.ly/3lnLa6w

PsychU Article | Federal Appeals Court Prohibits Arresting Homeless People For Sleeping In Public When Shelter Beds Are Insufficient: https://bit.ly/3Ptv0GF

PsychU Article | Connecticut, New Mexico, New York & Virginia Legalized Recreational Use of Marijuana in 2021: https://bit.ly/3FVuTiP

Caroline Fisher-O’Neill, Amica Simmons-Yon and Alyssa Peckham are employees of Otsuka America Pharmaceutical, Inc

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

US.CORP.X.22.00154

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Managed Care & Value-Based Reimbursement with special guest, Madeline Shurtleff, PharmD. During this episode, Dr. Shurtleff highlights the difference between individual health plans and pharmacy benefit managers (PBMs), and how that differs among private insurers versus federal. She also tunes us into the inner workings of the two – namely, how they interact with one another and how decisions are made to deliver your health care. Lastly, Dr. Shurtleff let’s us know where we can find more information on managed care topics!

Dr. Shurtleff graduated from the University of Rhode Island College of Pharmacy. She started her pharmacy career as a pharmacist at Walgreens before transitioning to managed care. Her managed care experience includes managing utilization management pharmacist teams for various Medicare, Medicaid, and Dual Eligible Special Needs Plan (D-SNP) health plans. As a Managed Market Liaison with Otsuka, she helps to bridge clinical, economic, and disease state information to support better health outcomes for patients. She resides in Phoenix, Arizona.

Featuring:

• Madeline Shurtleff, PharmD; Managed Market Liaison, OPDC

• Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC

• Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC

Links:

PsychU Article | Ready, Set, Managed Care! https://bit.ly/3M6Oz4V

PsychU Article | Medicaid Managed Care – From 0 To 100: https://bit.ly/3jLOeZv

PsychU Interview | Mental Health & COVID-19: Managed Care Perspective: https://bit.ly/3jFWbzi

PsychU Article | Collaboration Between Managed Care & Mental Health Staff: Does It Improve Outcomes? https://bit.ly/3xAsUOD

PsychU Article | Medicare Managed Care Is On The Increase – At Consumer Request: https://bit.ly/3JRhk41

Madeline Shurtleff, Amica Simmons-Yon, and Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

US.CORP.X.22.00133

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on the hot topic of “medication adherence in Bipolar I Disorder”, with special guest, Dr. Joseph Goldberg. During this episode, Dr. Goldberg discusses the challenges of adherence in BP l Disorder. Our special guest will even spill the tea on where we can find more resources on this topic!

Featuring:



 Joseph Goldberg, MD

 Dr. Joseph Goldberg is a Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, is Director of the Affective Disorders Research Program at Silver Hill Hospital in New Canaan, CT, and serves as a Bipolar Section Advisor for PsychU. He has published several books and hundreds of peer-reviewed papers on topics related to the clinical features of bipolar disorder and psychopharmacology. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly's "America's Top Doctors."



 Amica Simmons-Yon, PharmD, PhD

 Clinical & Scientific Liaison, OPDC



 Alyssa Peckham, PharmD, BCPP

 Clinical & Scientific Liaison, OPDC

 

Links:

PsychU | Impact of Adherence on Patients with BP I Disorder: https://bit.ly/3LoqMxz

PsychU | Discussion Of Identifying Profiles Of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With A Long-Acting Injectable Antipsychotic: https://bit.ly/38cuTyd

PsychU | A Shot For Bipolar I Disorder? Identifying Appropriate Patient Profiles For Maintenance Therapy With Long Acting Injectable Medications: https://bit.ly/3iG82wC

PsychU | A Look At Adherence In Bipolar Disorder: https://bit.ly/3LgrIn2

PsychU | Treatment Adherence In Mental Health: https://bit.ly/3DgC7wg

PsychU | Bipolar Section Advisor Perspective On The COVID-19 Pandemic An Interview With Dr. Joseph Goldberg: https://bit.ly/36SDW6y

Research-based Expertise in the Psychopharmacology of Mood Disorders (josephgoldbergmd.com): https://bit.ly/3uD0ssg

DBSA - Depression and Bipolar Support Alliance (dbsalliance.org): https://bit.ly/36yaLpD

Joseph Goldberg is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc

Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

US.CORP.X.22.00155/

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Psychiatric Advance Directives with special guest, Dr. Leon Ravin. During this episode, Dr. Ravin highlights Psychiatric Advance Directives, its value to the patient at the time of a psychiatric crisis and the impact of the document on the therapeutic alliance and patient outcomes. Dr. Ravin is a Psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada. He is an educator and serves in key committees on the National Association of State Mental Health Program Directors, SMI Advisor (an APA and SAMHSA initiative), and the National Psychopharmacology Update.

US.CORP.X.22.00092

Featuring:

• Leon Ravin, MD; Co-Founder of Progressive Therapeutics

• Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC

• Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC

Links:

PsychU| Psychiatric Advance Directives Fact Sheet: https://bit.ly/3isYlBB

PsychU| Psychiatric Advance Directives – An Introduction: https://bit.ly/36IcsQT

PsychU| Psychiatric Advance Directives – A Deep Dive: https://bit.ly/3D3mgRQ

PsychU: Psychiatric Advance Directives – Logistic Nuts & Blots: https://bit.ly/3qxCbCL

NAMI| Psychiatric Advance Directives: https://bit.ly/3It3Gnj

National Resource Center for Psychiatric Advance Directives: https://bit.ly/3542rgv

Leon Ravin is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc

Amica Simmons-Yon & Alyssa are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Digital Health & Telepsychiatry with special guest, Dr. Nimish Shah. During this episode, Dr. Shah highlights the pros and cons of telehealth while discussing ways to deliver high quality psychiatric care. Dr. Nimish Shah is a co-founder and provider at Progressive Therapeutics where he has a longstanding commitment to excellence in delivery of patient care. In practice, Dr. Shah teaches the art and science of 21st century mental health care to master’s level nursing students from Northeastern University. He also plays a key role at PsychU.org as a clinical expert on the speakers bureau providing resources to the professional community.

Featuring:

• Nimish Shah, DNP; Co-Founder of Progressive Therapeutics

• Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC

• Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC

Links:

Progressive Therapeutics allays telehealth security concerns with EHR integration | Healthcare IT News: https://bit.ly/3L4TyU7

Dr. Nimish Shah DNP - PTX: https://bit.ly/3gggdP9

PsychU | Ready For The Digital Health Revolution? Note: It’s Not Just Telehealth: https://bit.ly/3gj0uPo

PsychU | Privacy & Security In Digital Health: https://bit.ly/3okfOj8

PsychU | Navigating Telepsychiatry In Mental Health Care: A Discussion With A Peer Specialist & A Caregiver: https://bit.ly/3Gm99eo

PsychU | Telepsychiatry In Mental Healthcare: Potential Benefits & Guidelines: https://bit.ly/3HoBceE

Nimish Shah is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc

Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Alyssa Peckham is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Dennis Sholler, PhD as they spill the tea on adherence in schizophrenia with special guest, Kathy Day. During this episode, Kathy Day highlights a recent interview where she discusses the most important factors that impact adherence from a patient and caregiver perspective. Kathy is a caregiver and a mental health advocate; she also plays a key role in PsychU.org as Section Advisor of the Patient & Caregiver Resource Center.

Featuring:

• Kathy Day, MPA, BA, AA; Patient & Caregiver Section Advisor

• Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC

• Dennis Sholler, PhD; Clinical & Scientific Liaison, OPDC

#mentalhealth

PsychU | Patient & Caregiver Resource Center

https://bit.ly/3nvh6I2

PsychU | Adherence In Schizophrenia: A Patient & Caregiver Perspective

https://bit.ly/3FsNh14

Kathy Day is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc

Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Dennis Sholler is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Aneta Fornal, PharmD as they spill the tea about this week’s hot topic on insights around Suicide & Black Americans with special guest, Sherry Molock, PhD, LCSW. Dr. Molock is an Associate Professor in the Department of Psychological & Brain Sciences at The George Washington University. Dr. Molock has over 20 years of experience in suicide prevention among Black American communities and is a founding pastor of the Beloved Community Church in Maryland. Join the PsychU Podcast team this week and learn more about Suicide & Black Americans.

Featuring:

• Amica Simmons-Yon, PharmD, PhD, OPDC CSL

• Aneta Fornal, PharmD, OPDC Sr. CSL

• Sherry Molock, PhD, M.Div., Associate Professor, George Washington University

PsychU | Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3jKRQeD

PsychU | Suicide Awareness: https://bit.ly/3blQ9Q4

PsychU | Addressing Racial Bias In Health Care: Practice & Organizational Perspectives: https://bit.ly/3vULIFF

PsychU | Diversity, Equity, & Inclusion: https://bit.ly/3jN9hLH

Home | AFSP: https://bit.ly/3Gth4YB

Suicide Prevention Resource Center: https://bit.ly/3w0pOkb

Amica Simmons-Yon and Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Sherry Molock is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic in celebration of Pharmacists Month. With special guests Dr.’s Ehret and Silvia, they will discuss what’s going on in the Pharmacist Corner and explain the role of pharmacists in depression management.

Megan Ehret, PharmD, MS, BCPP is a psychiatric pharmacist and a Professor at the University of Maryland School of Pharmacy. Dr. Ehret is also the Past-President of CPNP and the current Section Editor for the Pharmacist Corner on PsychU. Richard Silvia, PharmD, BCPP is Professor at the Massachusetts College of Pharmacy and Health Sciences. Dr. Silvia maintains a practice site at the Codman Square Health Center, in Dorchester, MA. Join the PsychU Podcast team this week and learn more about the role of Pharmacists in depression management.

Featuring:

• Amica Simmons-Yon, PharmD, PhD, OPDC MSL

• Jacquelyn Canning, PharmD, BCPP, OPDC Sr. MSL

• Megan Ehret, PharmD, MS, BCPP

• Richard Silvia, PharmD, BCPP

#MDD #PharmacistsMonth #PharmD

The Role Of The Pharmacist In The Treatment Of Depression - PsychU: https://bit.ly/3peY7ms

Suicide Stratification Risk Models & The Role Of Pharmacists In Suicide Education & Prevention - PsychU: https://bit.ly/30xH9VX

Pharmacist Corner - PsychU: https://bit.ly/3jdtudn

Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Megan Ehret and Richard Silvia are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

US.CORP.X.21.00677

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Aneta Fornal, PharmD as they spill the tea about this week’s hot topic on the mission and insights around Youth Suicide Prevention with special guest, Jonathan Singer, PhD, LCSW. Dr. Singer is an Associate Professor in the School of Social Work at Loyola University Chicago, and he is the founder and host of the award-winning Social Work Podcast. Honorably, Dr. Singer most recently served as the former President of the American Association of Suicidology. Join the PsychU Podcast team this week and learn more about Youth Suicide Prevention.

Featuring:

• Amica Simmons-Yon, PharmD, PhD, OPDC MSL

• Jacquelyn Canning, PharmD, BCPP, OPDC Sr. MSL

• Aneta Fornal, PharmD, OPDC Sr. MSL

• Jonathan Singer, PhD, LCSW; Associate Professor, Loyola University Chicago

Suicide Awareness - PsychU

• https://bit.ly/3zTSbRy

PsychU | Suicide & Black Americans: Statistics, Faith, & Contextual Competence

• https://bit.ly/3m7abTw

For Better Or Worse? Bridging The Care Continuum For Mental Health Services In Our New Reality - PsychU

• https://bit.ly/3kTc6LT

https://socialworkpodcast.com

• https://bit.ly/3F3Akvd

If you or someone you know is in crisis, please contact the Suicide Prevention Hotline / Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line at 741-741

Amica Simmons-Yon, Jacquelyn Canning and Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Jonathan Singer is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: Neuroimaging in Schizophrenia with a special guest, Anissa Abi-Dargham, MD. Dr. Abi-Dargham is the Vice-Chair of Research, Department of Psychiatry & Behavioral Health, Stony Brook University. Join the PsychU podcast team this week and learn more about updates in neuroimaging in schizophrenia and future directions in research.

Featuring:

• Amica Simmons-Yon, PharmD, PhD, OPDC MSL

• Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL

• Anissa Abi-Dargham, MD

Neuroimaging Updates In Schizophrenia & The Future Of Precision Medicine: An Interview With Dr. Anissa Abi-Dargham - PsychU

https://bit.ly/3AV0b5L

Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Anissa Abi-Dargham, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.